Centessa Pharmaceuticals PLC ADR (CNTA) Insider Trading
- $3,235,137.92
- $17,056,443.14
- April 21, 2025
- Saurabh Saha
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 21, 2025 | CEO | 14,656 | $12.29 | Sell | $180,122.24 | |
March 25, 2025 | Insider | 10,000 | $16.34 | Sell | $163,400.00 | |
March 20, 2025 | CEO | 55,000 | $16.69 | Sell | $917,950.00 | |
March 17, 2025 | Insider | 7,000 | $17.17 | Sell | $120,190.00 | |
March 17, 2025 | General Counsel | 6,000 | $16.45 | Sell | $98,700.00 | |
Feb. 20, 2025 | CEO | 55,000 | $15.93 | Sell | $876,150.00 | |
Feb. 18, 2025 | General Counsel | 6,000 | $16.18 | Sell | $97,080.00 | |
Feb. 10, 2025 | Insider | 429 | $18.99 | Sell | $8,146.71 | |
Feb. 7, 2025 | Insider | 30,526 | $19.03 | Sell | $580,909.78 | |
Feb. 3, 2025 | CTO | 11,000 | $16.86 | Sell | $185,460.00 | |
Feb. 3, 2025 | Insider | 6,471 | $16.86 | Sell | $109,101.06 | |
Jan. 27, 2025 | Insider | 11,742 | $16.47 | Sell | $193,390.74 | |
Jan. 21, 2025 | CEO | 55,000 | $15.77 | Sell | $867,350.00 | |
Jan. 15, 2025 | General Counsel | 6,000 | $15.29 | Sell | $91,740.00 | |
Dec. 26, 2024 | Insider | 10,000 | $17.04 | Sell | $170,400.00 | |
Dec. 20, 2024 | CEO | 55,000 | $17.44 | Sell | $959,200.00 | |
Dec. 17, 2024 | Insider | 10,624 | $17.32 | Sell | $184,007.68 | |
Dec. 17, 2024 | CTO | 17,813 | $18.00 | Sell | $320,634.00 | |
Dec. 16, 2024 | General Counsel | 77,705 | $16.39 | Sell | $1,273,584.95 | |
Dec. 13, 2024 | Insider | 5,876 | $17.01 | Sell | $99,950.76 | |
Dec. 6, 2024 | CEO | 87,496 | $18.46 | Sell | $1,615,176.16 | |
Nov. 25, 2024 | Insider | 10,000 | $17.66 | Sell | $176,600.00 | |
Nov. 25, 2024 | CEO | 299 | $18.23 | Sell | $5,450.77 | |
Nov. 22, 2024 | CEO | 1,671 | $18.24 | Sell | $30,479.04 | |
Nov. 20, 2024 | CEO | 55,000 | $16.89 | Sell | $928,950.00 | |
Oct. 25, 2024 | Insider | 11,742 | $15.38 | Sell | $180,591.96 | |
Oct. 23, 2024 | CEO | 2,592 | $15.32 | Sell | $39,709.44 | |
Oct. 21, 2024 | CEO | 22,205 | $15.80 | Sell | $350,839.00 | |
Sept. 25, 2024 | Insider | 16,619 | $15.69 | Sell | $260,752.11 | |
Sept. 20, 2024 | CEO | 55,000 | $16.53 | Sell | $909,150.00 | |
Sept. 10, 2024 | CEO | 175,000 | $16.52 | Sell | $2,891,000.00 | |
Sept. 9, 2024 | Insider | 25,000 | $15.00 | Sell | $375,000.00 | |
Aug. 22, 2024 | Insider | 12,198 | $12.17 | Sell | $148,449.66 | |
Aug. 22, 2024 | CEO | 506 | $12.23 | Sell | $6,188.38 | |
Aug. 20, 2024 | CEO | 4,169 | $12.32 | Sell | $51,362.08 | |
March 25, 2024 | Insider | 51,160 | $11.88 | Sell | $607,780.80 | |
Feb. 1, 2024 | SVP | 4,267 | $8.10 | Sell | $34,562.70 | |
Sept. 20, 2023 | SVP | 37,484 | $6.29 | Sell | $235,774.36 | |
June 1, 2023 | EVP | 6,500 | $4.45 | Sell | $28,925.00 | |
May 24, 2023 | Insider | 8,000 | $4.48 | Sell | $35,840.00 | |
May 1, 2023 | EVP | 6,800 | $4.42 | Sell | $30,056.00 | |
Jan. 4, 2023 | EVP | 6,970 | $3.18 | Sell | $22,164.60 | |
Dec. 1, 2022 | EVP | 9,400 | $3.91 | Sell | $36,754.00 | |
Nov. 1, 2022 | EVP | 9,700 | $4.03 | Sell | $39,091.00 | |
Oct. 3, 2022 | Insider | 4,167 | $3.95 | Sell | $16,459.65 | |
Oct. 3, 2022 | General Counsel | 4,563 | $3.95 | Sell | $18,023.85 | |
Oct. 3, 2022 | CTO | 2,455 | $3.95 | Sell | $9,697.25 | |
Oct. 3, 2022 | CFO | 4,901 | $3.95 | Sell | $19,358.95 | |
Oct. 3, 2022 | EVP | 12,524 | $3.92 | Sell | $49,094.08 | |
Sept. 30, 2022 | General Counsel | 3,725 | $4.07 | Sell | $15,160.75 |
Insiders are both buying and selling Centessa Pharmaceuticals PLC ADR stock.
The insider traders at Centessa Pharmaceuticals PLC ADR are: Saurabh Saha, Antoine Yver, Gregory M Weinhoff, Iqbal J Hussain, Karen M Anderson, Tia L Bush, Rubertis Francesco De, David M Chao, Medicxi Ventures Management (J, Harris Rotman, Thomas Templeman, David J Grainger, and Aaron Kantoff
The most active insider trader at Centessa Pharmaceuticals PLC ADR is Saurabh Saha with 18 trades.
Saurabh Saha has sold the most Centessa Pharmaceuticals PLC ADR stock with a total value of $10,809,199.35.
Rubertis Francesco De has bought the most Centessa Pharmaceuticals PLC ADR stock with a total value of $2,319,537.94.
The most recent insider trade for Centessa Pharmaceuticals PLC ADR was on April 21, 2025.
The single biggest insider buy for Centessa Pharmaceuticals PLC ADR was from Rubertis Francesco De with a total value of $761,036.48 on Dec. 1, 2021.
The single biggest insider sell for Centessa Pharmaceuticals PLC ADR was from Saurabh Saha with a total value of $2,891,000.00 on Sept. 10, 2024.